A Case Report: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Treated with Venetoclax, Hypomethylating agent, and Tagraxofusp - Abstract
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare subtype of myeloid neoplasm, often presenting as cutaneous skin lesions and nodules in elderly males. The diagnosis of BPDCN is often challenging as it can resemble lymphoblasts or small immunoblasts, requiring the utilization of large panel antibodies to characterize the disease. As BPDCN remains a rare disease, there is no consensus on optimal therapy. We present a case report that describes the clinical presentation, pathologic diagnosis, treatment, and outcome of a patient with BPDCN